560075-65-2Diclofenac EP Impurity F
● In Stock
| Catalogue No.: | VL48005 |
|---|---|
| CAS No.: | 560075-65-2 |
| Mol. Formula: | C14H10Cl3NO |
| Mol. Weight: | 314.59 g/mol |
Additional information on CAS 560075-65-2
Parent drug
DiclofenacIUPAC Name
N-(4-chlorophenyl)-2-(2,6-dichlorophenyl)acetamidePharmacopeial Synonyms
Diclofenac Acetamide; Diclofenac Related Compound FSynonyms
2,6-dichloro-n-(4-chlorophenyl)benzeneacetamideSmiles
O=C(NC1=CC=C(Cl)C=C1)CC2=C(Cl)C=CC=C2ClInChI
InChI=1S/C14H10Cl3NO/c15-9-4-6-10(7-5-9)18-14(19)8-11-12(16)2-1-3-13(11)17/h1-7H,8H2,(H,18,19)Shipping Condition
Ambient TemperatureDescription
Diclofenac EP Impurity F, also designated Diclofenac Related Compound F or Diclofenac Acetamide, is the anilide acetamide analogue of diclofenac with CAS 560075-65-2, molecular formula C14H10Cl3NO, and molecular weight 314.59 g/mol. Structurally, it reflects amide formation at the phenylacetic side chain and is typically associated with synthetic or hydrolytic side reactions during diclofenac manufacture. Because the molecule contains three chloro substituents and a non-ionizable amide, trace-level assessment generally requires LC-MS/MS or LC-HRMS, often complemented by LC-UV and, where volatility permits, GC-MS confirmation. Its presence is relevant to impurity profiling and process characterization under pharmacopoeial and ICH impurity frameworks.References
Sun, Wei, et al. “Crystal Structure of N-(4-Chlorophenyl)-2-(2, 6-Dichlorophenyl)Acetamide, C14H10Cl3NO.” Zeitschrift Für Kristallographie – New Crystal Structures, vol. 233, no. 5, Aug. 2018, pp. 913–14, https://doi.org/10.1515/ncrs-2018-0096 Todd, Peter A., and Eugene M. Sorkin. “Diclofenac Sodium.” Drugs, vol. 35, no. 3, Mar. 1988, pp. 244–85, https://doi.org/10.2165/00003495-198835030-00004.Request a Quote
"*" indicates required fields









